Skip to main content
Equibles

DRUG · Bright Minds Biosciences Inc.

Use DRUG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DRUG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
26.0000 CAD -0.1100 (-0.42%) At close · Nov 5 Intraday price with Plus
Rebalance outlook locked

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close26.0000 CAD Open26.0000 CAD Day26.0000–26.0000 CAD 52W close26.0000–131.8800 CAD Avg vol 30d613 Last earningsJan 6, 2026 DataJul 2023–Nov 2026

Raw chart and full-history price indicators begin at the captured split on Jul 14, 2023; bars on opposite sides are not compared.

Latest documents

2026
Nov 2
Current report 6-K
Current report

Bright Minds Biosciences Inc. said the FDA partially held the BMB-101 IND for Developmental and Epileptic Encephalopathies, citing mouse toxicity and inadequate pharmacokinetic and juvenile toxicity data for pediatric enrollment; other ongoing clinical trials are believed unaffected.

Oct 2
Current report 6-K
Current report

At its March 31, 2026 annual general meeting, Bright Minds Biosciences Inc. elected all six director nominees and appointed De Visser Gray LLP as auditor; 7,877,637 common shares represented 80.49% of votes attached to outstanding shares.

All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 26.0000 CAD Now 26.0000 CAD · 0% Range high 131.8800 CAD
vs 200-day avg -74% vs 50-day avg -67%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Jul 14, 2023; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XCNQ:DRUG -67.3% -64.7% -78.5% -66.2% -76.5%

Exchange listing

Market
XCNQ
Ticker
DRUG
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company with tickers: DRUG

Company

Website
https://brightmindsbio.com/
Investor relations
https://investors.brightmindsbio.com/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Latest price

Plus & Pro

Follow DRUG during the session: the latest price, the day's change, range and volume. Closing prices stay free.

View plans Sign in

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q1 2026 2026-01-06
    Earnings conference call (announced in 6-K)